These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8412794)

  • 1. Tissue factor pathway inhibitor.
    Girard TJ; Broze GJ
    Methods Enzymol; 1993; 222():195-209. PubMed ID: 8412794
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
    Novotny WF; Girard TJ; Miletich JP; Broze GJ
    J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrinsic pathway proteolytic activity.
    Lawson JH; Krishnaswamy S; Butenas S; Mann KG
    Methods Enzymol; 1993; 222():177-95. PubMed ID: 8412793
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T; Franssen J; Willems G
    Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
    Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
    J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human factor IX and factor IXa.
    Bajaj SP; Birktoft JJ
    Methods Enzymol; 1993; 222():96-128. PubMed ID: 8412817
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor XI: structure-function relationships utilizing monoclonal antibodies protein modification, computational chemistry, and rational synthetic peptide design.
    Walsh PN; Baglia FA; Jameson BA
    Methods Enzymol; 1993; 222():65-96. PubMed ID: 8412816
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin.
    Jesty J; Wun TC; Lorenz A
    Biochemistry; 1994 Oct; 33(42):12686-94. PubMed ID: 7918495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of guinea pig uterus phosphoinositide-specific phospholipase C.
    Bennett CF; Angioli MP; Crooke ST
    Methods Enzymol; 1991; 197():526-35. PubMed ID: 1646940
    [No Abstract]   [Full Text] [Related]  

  • 12. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of protein phosphatase 1 complexes.
    Cohen PT; Browne GJ; Delibegovic M; Munro S
    Methods Enzymol; 2003; 366():135-44. PubMed ID: 14674246
    [No Abstract]   [Full Text] [Related]  

  • 14. A sulfated rabbit endothelial cell glycoprotein that inhibits factor VIIa/tissue factor is functionally and immunologically identical to rabbit extrinsic pathway inhibitor (EPI).
    Warn-Cramer BJ; Maki SL; Rapaport SI
    Thromb Res; 1991 Mar; 61(5-6):515-27. PubMed ID: 2028453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and properties of mitogen-activated S6 kinase from rat liver and 3T3 cells.
    Lane HA; Thomas G
    Methods Enzymol; 1991; 200():268-91. PubMed ID: 1956322
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification of G proteins.
    Codina J; Carty DJ; Birnbaumer L; Iyengar R
    Methods Enzymol; 1991; 195():177-88. PubMed ID: 1851927
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet membrane glycoprotein IIb-IIIa complex: purification, characterization, and reconstitution into phospholipid vesicles.
    Phillips DR; Fitzgerald L; Parise L; Steiner B
    Methods Enzymol; 1992; 215():244-63. PubMed ID: 1435325
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of factor VIIa/tissue factor by antithrombin III and tissue factor pathway inhibitor.
    Broze GJ; Likert K; Higuchi D
    Blood; 1993 Sep; 82(5):1679-81. PubMed ID: 8364216
    [No Abstract]   [Full Text] [Related]  

  • 19. Micro- and macropurification methods for protein kinases.
    Ferrari S; Thomas G
    Methods Enzymol; 1991; 200():159-69. PubMed ID: 1956316
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
    Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
    J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.